These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9632021)

  • 41. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
    Feldman SR; Levi E; Pathak P; Kakatkar S; Balkrishnan R
    J Med Econ; 2013 Dec; 16(12):1405-13. PubMed ID: 24063352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcipotriol ointment for plaque psoriasis.
    Drug Ther Bull; 1992 Mar; 30(5):17-8. PubMed ID: 1591988
    [No Abstract]   [Full Text] [Related]  

  • 44. [Psoriasis].
    el Sayed F; Marguery MC
    Ann Dermatol Venereol; 1997; 124(1):91-101. PubMed ID: 9686048
    [No Abstract]   [Full Text] [Related]  

  • 45. New topicals for mild and moderate psoriasis.
    Cooper CW
    JAAPA; 1999 Apr; 12(4):52-4, 57-60. PubMed ID: 10728082
    [No Abstract]   [Full Text] [Related]  

  • 46. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
    Lebwohl M; Yoles A; Lombardi K; Lou W
    J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
    Koo J; Tyring S; Werschler WP; Bruce S; Olesen M; Villumsen J; Bagel J
    J Dermatolog Treat; 2016; 27(2):120-7. PubMed ID: 26444907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.
    Del Rosso JQ
    Cutis; 2014 Sep; 94(3):127-34. PubMed ID: 25279474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sorilux (calcipotriene) foam 0.005%.
    Abramovits W; Oquendo M; Scheinfeld N; Gupta AK
    Skinmed; 2012; 10(5):301-4. PubMed ID: 23163073
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term effectiveness and safety of topical calcipotriene for psoriasis. Calcipotriene Study Group.
    Cullen SI
    South Med J; 1996 Nov; 89(11):1053-6. PubMed ID: 8903286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The efficacy of Psorcutan in the therapy of psoriasis].
    Komaristov IA; Glad'ko VV; Trubin AB; Volkova OA
    Voen Med Zh; 1997 Nov; 318(11):47-8. PubMed ID: 9461837
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of psoriasis with calcipotriene plus psoralen-UV-A-bath therapy.
    Grundmann-Kollmann M; Behrens S; Krähn G; Leiter U; Ochsendorf F; Kaufmann R; Peter RU; Kerscher M
    Arch Dermatol; 1999 Jul; 135(7):861-2. PubMed ID: 10411175
    [No Abstract]   [Full Text] [Related]  

  • 54. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypercalcaemia and hypercalciuria after topical treatment of psoriasis with excessive amounts of calcipotriol.
    Georgiou S; Tsambaos D
    Acta Derm Venereol; 1999 Jan; 79(1):86. PubMed ID: 10086871
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
    Sandoval LF; Huang KE; Harrison J; Clark A; Feldman SR
    Cutis; 2014 Dec; 94(6):304-9. PubMed ID: 25566573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding topical therapies for psoriasis.
    Stein Gold LF; Kircik LH; Pariser DM
    Cutis; 2019 Apr; 103(4S):S8-S12. PubMed ID: 31116805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An unusual bullous eruption in a patient with psoriasis: Calcipotriene phototoxicity.
    Anolik R; Brauer JA; Soter NA
    J Am Acad Dermatol; 2010 Jun; 62(6):1081-2. PubMed ID: 20466193
    [No Abstract]   [Full Text] [Related]  

  • 59. Trends in on and off-label calcipotriene use.
    Pearce DJ; Camacho F; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2006; 17(5):308-13. PubMed ID: 17092863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.